Filter
447
Text search:
registered
pharmaceutical
product
Featured
Recommendations
38
New Publications
135
Language
Document type
No document type
266
Studies & Reports
66
Guidelines
61
Manuals
24
Strategic & Response Plan
13
Training Material
7
Fact sheets
5
Situation Updates
4
Resource Platforms
1
Countries / Regions
Kenya
24
Ethiopia
23
South Africa
19
Uganda
16
India
16
Nigeria
15
Liberia
14
Tanzania
14
Malawi
13
Zimbabwe
12
Sierra Leone
11
Ghana
11
Rwanda
11
Zambia
8
Western and Central Europe
8
Bangladesh
7
Namibia
7
Eswatini/ Swaziland
7
Nepal
6
Botswana
6
Global
6
Philippines
5
Lesotho
5
Cambodia
4
Indonesia
4
Ukraine
4
Myanmar / Burma
4
Senegal
3
Haiti
3
Syria
3
Eastern Europe
3
Albania
3
Sudan
2
Benin
2
North Macedonia
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
China
1
Ireland
1
Mozambique
1
Central African Republic
1
Libya
1
Angola
1
South–East Asia Region
1
Asia
1
Africa
1
Venezuela
1
Southern Africa
1
Russia
1
Bulgaria
1
Moldova
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
20
Pharmacy & Technologies
18
Key Resources
13
Public Health
10
Capacity Building
5
Women & Child Health
5
Toolboxes
Pharmacy
64
AMR
42
TB
25
HIV
19
COVID-19
15
Mental Health
14
NTDs
8
Conflict
7
Global Health Education
5
Caregiver
5
Rapid Response
4
Disability
3
Planetary Health
3
Specific Hazards
2
Ebola
1
Cholera
1
Polio
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
Rwanda: FEES FOR REGISTRATION OF PHARMACEUTICAL PRODUCTS, MEDICAL DEVICES AND OTHER RELATED SERVICES
MINISTERIAL ORDER Nº 002/17/10/TC OF 27/10/2017 DETERMINING THE FEES FOR REGISTRATION OF PHARMACEUTICAL PRODUCTS, MEDICAL DEVICES AND OTHER RELATED SERVICES | Official Gazette nº 46 of 13/11/2017
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi
...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu
...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the pop
...
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and service providers in (1) estimating the total commodity needs and costs for successful implementation
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Revision Bulletin ESPNF